Eric Harvey

Eric has a passion for data and collaborating to turn that data into actionable information. A problem solver at heart, Eric focuses on identified cross-functional opportunities to increase efficiency and improve quality, including leveraging and adopting methodologies from other industries that positively impact early risk identification and selection of appropriate therapy targets. He leads MMS teams by keeping abreast of state-of-the-art technologies in data science and adaptive trial designs, and supporting initiatives that include risk management in data anonymization. Under his leadership in data science, MMS established a Health Analytics Collective with leading academic institutions.

Prior to MMS, Eric has led multiple biostatistics, programming, data science, data management, and information technology groups that include PRA Health Sciences, Health Decisions, and Quintiles (IQVIA). He holds several programming and quality certifications, including a six sigma black belt certification, and earned a Doctor of Philosophy in Biostatistics from the Virginia Commonwealth University School of Medicine. He also is actively involved in multiple industry organizations and routinely presents and teaches college courses on data science, statistics, and programming topics.

Suggested For You

perspectives

December 17th, 2024

Oncology Drug Development: Webinar Learnings on the Use of Expedited Pathways and Oncology Center of Excellence Programs

perspectives

December 11th, 2024

Why Emerging Biotech Companies are Increasingly Turning to Specialized Data CROs

regulatory intelligence

December 4th, 2024

FDA Issues Detailed Guidance on Development of Gene Therapy Products

news

December 4th, 2024

AI in Pharma and Innovative Leadership Were on Display at the Biennial MMS Scientific Symposium

perspectives

November 26th, 2024

Finding GRASEland: Navigating the New Regulatory Path for Grandfathered OTC Drugs 

perspectives

November 21st, 2024

Essential Nonclinical Strategies for Cell and Gene Therapy (CGT) Success

news

November 19th, 2024

MMS Recognized as a Top Workplace by Detroit Free Press and USA Today Network for the Fourth Consecutive Year

perspectives

November 12th, 2024

REMS Logic Modeling: Applying FDA Guidance from November 2024 CDER Webinar

news

November 8th, 2024

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

perspectives

November 6th, 2024

How to Successfully Manage Rescue Studies and Turn Around Clinical Trials Facing Failure

perspectives

October 29th, 2024

Why Outsourcing QC of Regulatory and Medical Writing Documents is a Competitive Advantage for Large Pharma Companies

perspectives

October 22nd, 2024

Choosing the Right Clinical Trial Design: A Crucial Step in Protocol Development